FDA Clears AI-Powered Software for Lung Nodule Detection on Chest CT
The F.A.S.T. aiCockpit CT Lung Nodule reportedly facilitates enhanced CT workflow and automated reporting for evaluation of lung nodules
The Food and Drug Administration (FDA) has granted 510(k) clearance for the F.A.S.T. aiCockpit CT Lung Nodule, which may bolster workflow efficiencies with interpretation of chest computed tomography (CT) scans.
Available for two-dimensional (2D) and three-dimensional (3D) CT exams, the F.A.S.T. aiCockpit CT Lung Nodule facilitates efficient descriptions and measurements of lung nodules, and rejection of false positives, according to Fovia Ai, the developer of the software.
The newly FDA-cleared F.A.S.T. aiCockpit CT Lung Nodule reportedly facilitates enhanced workflows and reporting with assessment of lung nodules on chest CT scans. (Image courtesy of Fovia.Ai. (Image courtesy of Fovia.Ai.)
Once radiologists have completed their assessment and review of the findings, Fovia Ai said the F.A.S.T. aiCockpit CT Lung Nodule automatically forwards the final results for inclusion in the radiology report.
The company noted that the F.A.S.T. aiCockpit CT Lung Nodule allows for easy integration into existing PACS systems, universal viewers, and other AI platforms.
Emphasizing that the F.A.S.T. aiCockpit CT Lung Nodule is the initial component of the F.A.S.T. aiCockpit Universal AI Viewer, which will reportedly offer a variety of AI algorithms for radiology, according to Fovia.Ai.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
FDA Clears Ultrasound AI Detection for Pleural Effusion and Consolidation
June 18th 2025The 14th FDA-cleared AI software embedded in the Exo Iris ultrasound device reportedly enables automated detection of key pulmonary findings that may facilitate detection of pneumonia and tuberculosis in seconds.
Multinational Study Reaffirms Value of Adjunctive AI for Prostate MRI
June 16th 2025The use of adjunctive AI in biparametric prostate MRI exams led to 3.3 percent and 3.4 percent increases in the AUC and specificity, respectively, for clinically significant prostate cancer (csPCa) in a 360-person cohort drawn from 53 facilities.
